Investrix arrives at the Forum of Lutetia under full sail — wine in one hand, roasted pheasant in the other, grease on his fingers. His pitch: ServiceNow. Thirteen billion dollars in revenue. Fifty percent market share. Ninety-eight percent renewal rate. The stock is down fifty percent. He cannot entirely describe what the company does, but he is certain it is extraordinary.
Numerius has a question: "You want me to invest in a company whose product you cannot describe."
What follows is a debate about the difference between a great business and a great investment. ServiceNow's numbers are formidable — four point six billion in free cash flow, cRPO growing thirty-seven percent, six hundred customers paying over five million each. But at sixty times earnings, Numerius sees a stock that has priced in six independent assumptions going right simultaneously. Stock-based compensation runs nearly two billion a year. The buyback programme exists to offset dilution, not reward shareholders. And twelve point six billion in acquisitions in a single year raises a question nobody wants to answer: if organic growth is twenty percent, why spend that much?
Numerius assigns fifty-five percent confidence to the bull case — then recommends buying only a third now. Investrix agrees, under one condition involving the finest wine in Lutetia.
Topics: NOW stock analysis, ServiceNow valuation, SaaS metrics, AI seat compression, stock-based compensation, M&A integration risk, cRPO growth